140 related articles for article (PubMed ID: 26768599)
1. Stereoselective synthesis of oxazolidinonyl-fused piperidines of interest as selective muscarinic (M1) receptor agonists: a novel M1 allosteric modulator.
Broadley KJ; Buffat MG; Burnell E; Davies RH; Moreau X; Snee S; Thomas EJ
Org Biomol Chem; 2016 Feb; 14(6):2057-89. PubMed ID: 26768599
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 5-hydroxy-2,3,4,5-tetrahydro-[1H]-2-benzazepin-4-ones: selective antagonists of muscarinic (M3) receptors.
Bradshaw B; Evans P; Fletcher J; Lee AT; Mwashimba PG; Oehlrich D; Thomas EJ; Davies RH; Allen BC; Broadley KJ; Hamrouni A; Escargueil C
Org Biomol Chem; 2008 Jun; 6(12):2138-57. PubMed ID: 18528576
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of macrocyclic precursors of phomactins using [2,3]-Wittig rearrangements.
McGowan G; Thomas EJ
Org Biomol Chem; 2009 Jun; 7(12):2576-90. PubMed ID: 19503933
[TBL] [Abstract][Full Text] [Related]
4. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
[TBL] [Abstract][Full Text] [Related]
5. Total syntheses of pamamycin 607 and methyl nonactate: stereoselective cyclisation of homoallylic alcohols that had been prepared with remote stereocontrol using allylstannanes.
Germay O; Kumar N; Moore CG; Thomas EJ
Org Biomol Chem; 2012 Dec; 10(48):9709-33. PubMed ID: 23154487
[TBL] [Abstract][Full Text] [Related]
6. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.
Daval SB; Valant C; Bonnet D; Kellenberger E; Hibert M; Galzi JL; Ilien B
J Med Chem; 2012 Mar; 55(5):2125-43. PubMed ID: 22329602
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of epothilones using functionalised allylstannanes for remote stereocontrol.
Martin N; Thomas EJ
Org Biomol Chem; 2012 Oct; 10(39):7952-64. PubMed ID: 22940725
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of carboxylic amides by ring-opening of oxazolidinones with Grignard reagents.
Bensa D; Coldham I; Feinäugle P; Pathak RB; Butlin RJ
Org Biomol Chem; 2008 Apr; 6(8):1410-5. PubMed ID: 18385847
[TBL] [Abstract][Full Text] [Related]
10. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
[TBL] [Abstract][Full Text] [Related]
11. A structural study of (1RS,2SR,3RS,4SR,5RS)-2,4-dibenzoyl-1,3,5-triphenylcyclohexan-1-ol chloroform hemisolvate and (1RS,2SR,3RS,4SR,5RS)-2,4-dibenzoyl-1-phenyl-3,5-bis(2-methoxyphenyl)cyclohexan-1-ol.
Minyaev ME; Roitershtein DM; Nifant'ev IE; Ananyev IV; Minyaeva TV; Mikhaylyev TA
Acta Crystallogr C Struct Chem; 2015 Jun; 71(Pt 6):491-8. PubMed ID: 26044332
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M
Spearing PK; Cho HP; Luscombe VB; Blobaum AL; Boutaud O; Engers DW; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Bender AM
Bioorg Med Chem Lett; 2021 Sep; 47():128193. PubMed ID: 34118412
[TBL] [Abstract][Full Text] [Related]
13. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M
Jörg M; van der Westhuizen ET; Khajehali E; Burger WAC; White JM; Choy KHC; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ
ACS Chem Neurosci; 2019 Mar; 10(3):1099-1114. PubMed ID: 30547573
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and thermodynamic control in the stereoselective formation of trans- and cis-2-ferrocenyl-3-pivaloyl-4-alkyl-1,3-oxazolidin-5-ones.
Alonso F; Davies SG; Elend AS; Smith AD
Org Biomol Chem; 2009 Feb; 7(3):518-26. PubMed ID: 19156318
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
Sams AG; Hentzer M; Mikkelsen GK; Larsen K; Bundgaard C; Plath N; Christoffersen CT; Bang-Andersen B
J Med Chem; 2010 Sep; 53(17):6386-97. PubMed ID: 20684563
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.
Kuduk SD; Chang RK; Di Marco CN; Pitts DR; Greshock TJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Ray WJ
J Med Chem; 2011 Jul; 54(13):4773-80. PubMed ID: 21682298
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of substituted N-benzyl piperidines in the GBR series: Synthesis of 4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(2-trifluoromethylbenzyl)piperidine, an allosteric modulator of the serotonin transporter.
Boos TL; Greiner E; Calhoun WJ; Prisinzano TE; Nightingale B; Dersch CM; Rothman RB; Jacobson AE; Rice KC
Bioorg Med Chem; 2006 Jun; 14(11):3967-73. PubMed ID: 16563775
[TBL] [Abstract][Full Text] [Related]
19. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects.
Davoren JE; Lee CW; Garnsey M; Brodney MA; Cordes J; Dlugolenski K; Edgerton JR; Harris AR; Helal CJ; Jenkinson S; Kauffman GW; Kenakin TP; Lazzaro JT; Lotarski SM; Mao Y; Nason DM; Northcott C; Nottebaum L; O'Neil SV; Pettersen B; Popiolek M; Reinhart V; Salomon-Ferrer R; Steyn SJ; Webb D; Zhang L; Grimwood S
J Med Chem; 2016 Jul; 59(13):6313-28. PubMed ID: 27275946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
